Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil vs Amphetamines for Hypersomnolence
NCT03772314Phase 2Completed
- Sponsor
- Emory University
- Start
- Apr 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dextroamphetamine + amphetamine in narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) (2 arms), sponsored by Emory University. Primary endpoint: Epworth Sleepiness Scale at Week 12. Started Apr 2019; status: completed.
02
Drugs
dextroamphetamine + amphetamine
03
Conditions
narcolepsy type 2 (NT2)idiopathic hypersomnia (IH)
Beyond the preview
Go deeper on NCT03772314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772314.